Cold plasma devices produce an ionized gas that hovers near room temperature, allowing direct contact with living tissue, wounds, and heat-sensitive materials without causing burns. These devices generate a cocktail of short-lived reactive oxygen and nitrogen species that can kill bacteria, accelerate wound closure, and even selectively damage cancer cells in laboratory settings. The technology has moved from physics labs into certified medical products in parts of Europe and is being studied across wound care, dentistry, oncology, dermatology, food safety, and drug delivery. But the story is more layered than “plasma heals everything,” and the safety picture depends heavily on which device you are talking about.
What a Cold Plasma Device Actually Does
A cold plasma device takes a carrier gas and pushes it through an electric field strong enough to strip electrons from some of the gas molecules, creating a partially ionized cloud. The key word is “partially.” Unlike the superheated plasma inside a welding arc or the sun, cold atmospheric plasma (CAP) keeps its bulk gas temperature well below body temperature. Modern clinical devices are designed to stay below about 40 °C at the point of contact with skin.1PubMed Central. Clinical and Biological Principles of Cold Atmospheric Plasma Application in Skin Cancer That is what makes it safe to aim at a wound or a patient’s mouth.
The two most common device architectures are dielectric barrier discharge (DBD) devices and atmospheric pressure plasma jets (APPJ). DBD devices use an insulated electrode placed close to the target surface, with the tissue itself completing the circuit. Plasma jets push the ionized gas through a nozzle, forming a visible plume that can be directed like a pen. Helium and argon are the most common carrier gases, though some devices run on ambient air. A coaxial DBD reactor, for example, can sustain a helium discharge at roughly one watt of electrical power while producing electron densities on the order of tens of trillions per cubic centimeter.2Plasma Sources Science and Technology. Generation of cold atmospheric plasma jet by a coaxial double dielectric barrier reactor That is an extraordinarily energy-efficient way to generate a biologically active gas.
The composition of the reactive species coming out of any device depends on the feed gas and even on the humidity in the room. Systematic testing of an argon plasma jet across 65 different gas mixtures showed that adding oxygen to the feed gas reduced overall reactive species production, while adding nitrogen boosted nitrogen-associated chemistry. Humidity acted as a secondary tuning dial, with the strongest effects appearing when both oxygen and nitrogen were mixed in.3MDPI Plasma. Feed Gas Composition and Humidity Shape Reactive Species Signatures in a Clinical Cold Plasma Jet This matters because it means two devices that look similar can produce very different chemical outputs depending on their design and operating conditions.
How Cold Plasma Kills Bacteria and Affects Cells
The biological workhorse of cold plasma is the burst of reactive oxygen and nitrogen species it delivers. These include short-lived radicals like hydroxyl radicals and atomic oxygen, along with longer-lived molecules like hydrogen peroxide and nitrite. Physical plasmas generate unique mixes of these species, and a large body of research now tracks them from the gas phase all the way into liquids and biological tissue.4PubMed Central. ROS from Physical Plasmas: Redox Chemistry for Biomedical Therapy The species interact with cell membranes, DNA, and proteins in ways that depend on dose and exposure time.
Against bacteria, the mechanism involves membrane disruption. Research on biofilms from common pathogens found that underwater plasma treatment damaged cell membranes enough to release DNA and internal phosphate-containing materials into the surrounding water.5Scientific Reports. A submerged dielectric barrier discharge plasma inactivation mechanism of biofilms produced by Escherichia coli O157:H7, Cronobacter sakazakii, and Staphylococcus aureus Interestingly, not all plasma treatments kill bacteria through direct cell lysis. Testing against Enterococcus faecalis showed that CAP inactivated bacteria without immediately bursting the cells open, suggesting the killing mechanism can also involve intracellular damage rather than just punching holes in membranes.6PLOS ONE. Antibacterial efficacy of cold atmospheric plasma against Enterococcus faecalis planktonic cultures and biofilms in vitro
One of the more striking findings is that cold plasma works against antibiotic-resistant bacteria. Testing against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus showed that plasma jets achieved comparable killing of both strains, though DBD devices found MRSA slightly less susceptible than its non-resistant counterpart.7PubMed. In vitro susceptibility of methicillin-resistant and methicillin-susceptible strains of Staphylococcus aureus to two different cold atmospheric plasma sources Since the mechanism is fundamentally physical and chemical rather than pharmacological, bacteria cannot develop resistance to it the way they do to antibiotics. That alone has generated enormous interest from infection-control researchers.
Wound Healing and the Strongest Clinical Evidence
Wound care is where cold plasma devices have the most mature clinical data. The clearest trial evidence comes from a randomized study of patients with diabetic foot ulcers, a notoriously hard-to-heal wound type. Patients receiving CAP treatment saw their wound area shrink to roughly 30% of baseline, compared with about 55% remaining in the placebo group. The difference was statistically significant, and CAP-treated wounds also reached meaningful size reduction sooner.8JAMA Network Open. Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial
Beyond diabetic ulcers, broader reviews of the literature describe CAP as effective for both chronic and acute wounds. The proposed mechanisms include direct antimicrobial action on the wound surface, stimulation of growth factors and cell proliferation, and modulation of the inflammatory response.9PubMed Central. Advancing chronic and acute wound healing with cold atmospheric plasma: cellular and molecular mechanisms, benefits, risks, and future directions In practice, treatment sessions are short, typically a few minutes of plasma exposure per session, repeated over several visits. The fact that you can treat infected, fragile tissue without heat, without chemicals that sting, and without touching the wound is a real practical advantage for clinicians managing patients who are already in pain.
Dental Applications
Root canal infections are a persistent problem in dentistry, partly because the bacteria that colonize root canals (especially Enterococcus faecalis) form stubborn biofilms inside narrow, hard-to-reach spaces. Cold plasma offers a way to deliver antimicrobial action deep into these channels. A systematic review and meta-analysis of root canal disinfection studies found that CAP significantly reduced E. faecalis colony counts, with a large pooled effect size.10PubMed Central. Disinfection of dental root canals by cold atmospheric plasma: a systematic review and meta-analysis of dental biofilm
In one laboratory study, no detectable live bacteria remained after 12 minutes of cold plasma treatment inside root canals harboring three-week-old biofilms, a result confirmed by both electron microscopy and confocal laser imaging.11PubMed. Evaluation of Cold Plasma Treatment and Safety in Disinfecting 3-week Root Canal Enterococcus faecalis Biofilm In Vitro These are lab and bench-top results, not yet routine clinical practice, but they suggest CAP could eventually complement or partially replace chemical irrigants like sodium hypochlorite that carry their own tissue-irritation risks.
Cancer Research in the Lab
Cold plasma’s selectivity toward cancer cells over normal cells is one of the most-discussed findings in the field, and it is important to frame it accurately: this work is overwhelmingly in vitro, meaning it happens in cell cultures and animal models, not in patients. The observation is real, though. When prostate cancer cells and normal prostate cells were both exposed to plasma-activated media, the cancer cells’ survival dropped dramatically and their rate of programmed cell death rose from about 7% to nearly 43%, while normal cells were largely unaffected.12PubMed Central. Cold atmospheric plasma selectively induces G0/G1 cell cycle arrest and apoptosis in AR-independent prostate cancer cells Similar selectivity has been observed in lung cancer cell lines, where plasma treatment reduced viability of tumor cells without significant effects on normal endothelial cells.13Scientific Reports. Apoptotic effects of cold atmospheric pressure plasma on A549 and LL/2 lung carcinoma cell lines
The leading explanation is that cancer cells already operate under higher baseline oxidative stress than healthy cells. Adding a wave of reactive species from plasma pushes them past a survivable threshold, while normal cells have enough antioxidant capacity to cope. The gap between promising lab results and anything resembling a cancer treatment for humans remains large, though. No one should interpret current data as meaning cold plasma cures cancer. What the data do suggest is that the selective toxicity is worth investigating further, and several groups are exploring CAP as an adjunct to surgery or chemotherapy in early-phase trials.
Sterilizing Heat-Sensitive Medical Equipment
Autoclaving remains the gold standard for sterilizing surgical instruments, but plenty of medical devices, such as flexible endoscopes, plastic tubing, and electronic implant components, cannot survive the heat. Cold plasma has been explored as a low-temperature alternative since it can deliver sterilization-level microbial kill without exceeding temperatures that would warp or degrade these materials.14Plasma Processes and Polymers. Low Temperature Plasma‐Based Sterilization: Overview and State‐of‐the‐Art Radio-frequency driven plasma jets operating in argon at atmospheric pressure have been specifically tested for this purpose.15Contributions to Plasma Physics. Antimicrobial Treatment of Heat Sensitive Materials by Means of Atmospheric Pressure Rf‐Driven Plasma Jet
Recent work on a plasma-aerosol method showed impressive results against a panel of challenging organisms. The technique achieved germ reductions greater than 99.9999% against Enterococcus hirae, Staphylococcus aureus, and Enterococcus faecium, and better than 99.99% against Candida albicans and the spore-forming Clostridioides difficile, all without damaging the thermolabile devices being treated.16Scientific Reports. New approaches to disinfection of thermolabile medical devices using an indirect method with cold atmospheric plasma-aerosol C. difficile spores are famously resistant to many disinfectants, so achieving four-log-plus reductions against them with a room-temperature process is a meaningful result.
Safety Concerns and What the Evidence Shows
Because cold plasma generates reactive species capable of damaging cell membranes and DNA in bacteria, the obvious question is whether it damages the patient’s own tissue. The answer depends on dose, device, and duration, which is why safety must be evaluated per device rather than for the technology as a whole. European Medical Device Regulation requires separate safety assessment for each clinical plasma device, reflecting the fact that different designs produce different chemical outputs.17Journal of Wound Management. Cold Plasma: An Emerging Technology for Clinical Use in Wound Healing
Temperature is the simplest safety parameter. As noted earlier, modern clinical devices stay below 40 °C, well within the range that skin tolerates comfortably. The more subtle concern is chemical. Operating a plasma device generates ozone and nitrogen oxides as byproducts. Measurements during simulated wound treatment using a DBD device on porcine skin found ozone emission rates between 0.14 and 1.15 micrograms per second, which was considerably lower than rates previously measured against metal surfaces. Nitrogen oxide emissions were roughly a hundred times lower still.18Indoor Air. Assessment of Health Risks Associated With the Emission of Reactive Species During Routine Wound Treatment With a Medical Device Based on Cold Atmospheric Plasma In a well-ventilated treatment room, these levels are unlikely to pose a respiratory hazard, but the finding underscores that treatment surface matters: plasma interacting with metal generates more ozone than plasma interacting with tissue.
Genotoxicity testing has produced a nuanced picture. At higher plasma intensities, researchers observed DNA damage markers in exposed cells, including increased DNA strand breaks detected by the TUNEL assay and the appearance of double-strand break markers. However, a standard mutagenicity test (the Ames test) found that even at those higher intensities, CAP did not qualify as a mutagen. The mutagenic index stayed below the threshold that would classify the exposure as mutagenic.19PubMed Central. A Nonclinical Safety Evaluation of Cold Atmospheric Plasma for Medical Applications: The Role of Genotoxicity and Mutagenicity Studies The takeaway is that cold plasma can cause transient DNA damage at high doses, much like ultraviolet light or ionizing radiation can at high doses, but at the intensities and durations used clinically, the evidence so far does not suggest a mutagenic risk. Still, long-term follow-up data from large patient populations are thin, and this is an area where more study is genuinely needed.
Drug Delivery Through the Skin
An increasingly active research area is using cold plasma to push drugs through the skin barrier. Your skin is designed to keep things out, which is great for protection but frustrating when you need a topical medication to penetrate deeper. Cold plasma appears to open temporary pathways through the outer skin layer by oxidizing fatty acids in the lipid barrier and creating transient pores in cell membranes, a process sometimes compared to electroporation. This can enhance the skin’s permeability to drugs, nanoparticles, and large molecules that would otherwise sit on the surface.20PubMed. Cold atmospheric plasma in drug delivery and skin treatment
Even at low intensities designed to preserve cell viability, cold plasma treatment enabled large hydrophilic molecules to pass through keratinocytes, the dominant cells of the outer skin layer. Fluorescent tracer molecules in the range of 3,000 to 5,000 daltons were observed inside cells after plasma exposure, demonstrating that the barrier was permeabilized without destroying the cells.21Scientific Reports. Subcytotoxic transepidermal delivery using low intensity cold atmospheric plasma If this translates clinically, it could improve the delivery of topical chemotherapy agents, anti-inflammatory drugs, and wound-healing compounds while reducing the need for injections or systemic dosing.
Agriculture and Food Safety
Cold plasma’s antimicrobial properties have applications well beyond medicine. In agriculture, plasma treatment of ginseng seeds increased germination rates and simultaneously reduced bacterial and fungal contamination on the seed surface, with the antifungal effect outperforming the antibacterial effect.22PubMed Central. Enhancement of seed germination and microbial disinfection on ginseng by cold plasma treatment The dual benefit of decontamination and improved germination makes plasma treatment attractive as a chemical-free seed priming method, particularly for high-value crops where fungicide residues are undesirable.
Food safety researchers are also exploring plasma-activated water, which is ordinary water that has been treated with cold plasma to load it with reactive species. This water retains antimicrobial activity and can be sprayed onto produce or food contact surfaces. Storage stability matters for practical use: hydrogen peroxide concentrations in plasma-activated water stored at refrigerator temperature remained elevated for at least three months, suggesting the treated water could be prepared in batches and used over time rather than needing to be generated fresh for every application.23PubMed Central. Aging Stability and Radical Activity of Plasma-Activated Water Treated in Liquid- and Gas-Phase Reactors
Portable Devices and Where the Technology Is Heading
Early cold plasma setups were bulky laboratory instruments tethered to wall power and gas cylinders. The trend is toward smaller, more practical devices. One prototype demonstrated a fully battery-powered, portable plasma device running off a 12-volt rechargeable battery, capable of operating without being plugged into a wall outlet while still retaining the option of mains power when available.24Journal of Electrostatics. Design of a portable, battery-powered non-thermal atmospheric plasma device and characterization of its antibacterial efficacies Portability matters for battlefield medicine, rural clinics, veterinary applications, and home wound care scenarios where a patient cannot easily travel to a hospital for treatment.
Another avenue is air purification. An air-fed cold plasma device tested as a filter for airborne pathogens produced reactive species at concentrations around 10 micromolar in downstream water traps while generating no detectable ozone in the outgoing airstream.25Scientific Reports. Air-fed cold atmospheric plasma device as a safe and effective anti-SARS-CoV-2 air filter If the ozone output truly stays below detection limits during continuous operation, that removes one of the main concerns about running a plasma device in an enclosed room for extended periods. Air-fed devices are also appealing because they eliminate the need for compressed gas cylinders entirely, lowering cost and complexity.
The regulatory picture remains uneven. In Europe, several CAP devices have received CE marking under the Medical Device Regulation framework, which requires device-specific clinical evidence and safety testing. The United States has been slower to clear plasma devices for medical use, partly because the FDA has no established product category that fits neatly. Researchers and manufacturers are still working through the process of defining what evidence regulators need to see for each intended use, from wound care to dentistry to dermatology. In the meantime, the science continues to outpace the regulatory infrastructure, creating a gap between what studies show is possible and what clinicians can legally offer patients.